Clinical Trial Update: Treatment of REM Sleep Behavior Disorder (RBD) With Sodium Oxybate [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating sodium oxybate for REM Sleep Behavior Disorder with Parkinson's disease; study completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• Sodium Oxybate (Sodium Oxybate)

Snippet

Sponsor: Stanford University | Conditions: REM Sleep Behavior Disorder, Parkinson Disease | Phase 4 | Status: COMPLETED | Results posted: 2023-05-10